{"id":"W2801085776","doi":"10.1111/bjd.16724","title":"Safety of tildrakizumab for moderate-to-severe plaque psoriasis: pooled analysis of three randomized controlled trials","year":2018,"lang":"en","type":"article","venue":"British Journal of Dermatology","topic":"Psoriasis: Treatment and Pathogenesis","field":"Immunology and Microbiology","cited_by":75,"is_retracted":false,"has_abstract":true,"ca_institutions":"Queen's University; Probity Medical Research","funders":"Merck","keywords":"Medicine; Placebo; Adverse effect; Tolerability; Internal medicine; Etanercept; Psoriasis; Gastroenterology; Dermatology; Tumor necrosis factor alpha","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.003100699,0.0002810619,0.008952769,0.0008582445,0.0001554375,0.00001807194,0.000384449,0.0004753566,0.0005507606],"category_scores_gemma":[0.003830258,0.000228131,0.002895257,0.0004413904,0.000378451,0.0001069049,0.00004597315,0.0001638045,0.00001224056],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.00003407822,"about_ca_system_score_gemma":0.0002871692,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.00009502426,"about_ca_topic_score_gemma":0.0003646852,"domain_scores_codex":[0.9930546,0.002503164,0.003695977,0.0002574814,0.0001033284,0.0003854318],"domain_scores_gemma":[0.9904863,0.004953896,0.003085176,0.0002424075,0.001168566,0.00006365442],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.8473964,0.0005360654,0.0006641715,0.0000475284,0.1032115,0.000118858,0.0004209031,0.0001151505,0.01217393,0.0009495009,0.002893611,0.03147241],"study_design_scores_gemma":[0.8494012,0.0006978498,0.001981644,0.0003047904,0.0593699,0.006658809,0.0001841667,0.0001736913,0.07862711,0.001519587,0.0007057241,0.0003755669],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.952534,0.01947794,0.02238938,0.0006340108,0.001724352,0.002140534,0.000671064,0.00001988032,0.0004088329],"genre_scores_gemma":[0.9974474,0.0007978264,0.001235599,0.00009416918,0.0001044702,0.00008253774,0.00008055248,0.00002144878,0.0001359609],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.06645317,"threshold_uncertainty_score":0.930291,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01973450567562924,"score_gpt":0.2707364818393656,"score_spread":0.2510019761637363,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}